跳至主要内容
临床试验/ISRCTN95974322
ISRCTN95974322已完成不适用

Immunogenicity and safety of Brazilian combined vaccine against diphtheria, tetanus, pertussis, haemophilus influenzae type B and hepatitis B (DTPw/HB/hib)

Bio-Manguinhos/Fiocruz (Brazil)0 个研究点目标入组 1,200 人开始时间: 2008年6月30日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Healthy newborns (newborns and infants up to 7 months of age, of both sexes) whose parents/tutors understand the risk and benefits of the trial and agree to participate with written and informed consent.

排除标准

  • Newborns or mothers:
  • 1. Hepatitis B surface antigen (HBsAg) positive
  • 2. Human immunodeficiency virus (HIV) seropositive
  • 3. With positive serology for syphilis

研究者

发起方
Bio-Manguinhos/Fiocruz (Brazil)

相似试验